Roche has notified healthcare professionals that they have begun shipping additional quantities of Tamiflu (oseltamivir phosphate) oral suspension. Production of Tamiflu oral suspension was prioritized and increased in response to a supply shortage in September 2009. Roche continues to make all forms of Tamiflu, and increasing quantities of the oral suspension will become available through the beginning of 2010.
In the event that the oral suspension is unavailable, pharmacists may compound a suspension from Tamiflu 75mg capsules (final concentration 15mg/mL) using either of two vehicles: Cherry Syrup (from Humco) or Ora-Sweet SF (sugar-free) (from Paddock), following the FDA-approved instructions found in the Tamiflu Prescribing Information. In response to the shortage, Humco and Paddock Labs have increased production of Cherry Syrup and Ora-Sweet SF, respectively.
Tamiflu is available as a 12mg/mL oral suspension and as capsules in 30mg, 45mg, and 75mg dosage strengths.
For more information call (800) 526-6367 or visit www.tamiflu.com.